DE69000259T2 - Pharmazeutische zusammensetzung enthaltend 1-isopropyldihydrolysergsaeure. - Google Patents

Pharmazeutische zusammensetzung enthaltend 1-isopropyldihydrolysergsaeure.

Info

Publication number
DE69000259T2
DE69000259T2 DE9090300325T DE69000259T DE69000259T2 DE 69000259 T2 DE69000259 T2 DE 69000259T2 DE 9090300325 T DE9090300325 T DE 9090300325T DE 69000259 T DE69000259 T DE 69000259T DE 69000259 T2 DE69000259 T2 DE 69000259T2
Authority
DE
Germany
Prior art keywords
acid
isopropyldihydrolyse
pharmaceutical composition
composition containing
isopropyldihydrolysergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE9090300325T
Other languages
English (en)
Other versions
DE69000259D1 (de
Inventor
Marlene Lois Cohen
Mark Jay Goldberg
Louis Lemberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69000259D1 publication Critical patent/DE69000259D1/de
Publication of DE69000259T2 publication Critical patent/DE69000259T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
DE9090300325T 1989-01-17 1990-01-11 Pharmazeutische zusammensetzung enthaltend 1-isopropyldihydrolysergsaeure. Expired - Fee Related DE69000259T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/297,208 US4914107A (en) 1989-01-17 1989-01-17 Method for selectively blocking 5-HT2 receptors

Publications (2)

Publication Number Publication Date
DE69000259D1 DE69000259D1 (de) 1992-09-24
DE69000259T2 true DE69000259T2 (de) 1993-03-11

Family

ID=23145320

Family Applications (1)

Application Number Title Priority Date Filing Date
DE9090300325T Expired - Fee Related DE69000259T2 (de) 1989-01-17 1990-01-11 Pharmazeutische zusammensetzung enthaltend 1-isopropyldihydrolysergsaeure.

Country Status (9)

Country Link
US (1) US4914107A (de)
EP (1) EP0379308B1 (de)
JP (1) JPH02233680A (de)
AT (1) ATE79539T1 (de)
CA (1) CA2007472A1 (de)
DE (1) DE69000259T2 (de)
DK (1) DK0379308T3 (de)
ES (1) ES2044422T3 (de)
GR (1) GR3005963T3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996009069A1 (fr) * 1994-09-19 1996-03-28 Fujisawa Pharmaceutical Co., Ltd. Nouvelle utilisation medicale d'un antagoniste de 5ht¿3?
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB933082A (en) * 1960-10-06 1963-08-08 Sandoz Ag Improvements in or relating to lysergic acid derivatives
US3580916A (en) * 1969-02-20 1971-05-25 Lilly Co Eli Hydroxyesters of hexa- and octahydroindoloquinolines
SE396753B (sv) * 1970-05-18 1977-10-03 Richter Gedeon Vegyeszet Analogiforfarande for framstellning av en forening tillhorande dihydrolysergsyraserien
GB1413068A (en) * 1972-06-22 1975-11-05 Farmaceutici Italia Bromoergolines
DE3207775A1 (de) * 1981-03-13 1982-09-23 Sandoz-Patent-GmbH, 7850 Lörrach Verfahren zur herstellung von mutterkornalkaloiden
US4714704A (en) * 1985-10-01 1987-12-22 Eli Lilly And Company Alkoxy cycloalkanol esters of dihydrolysergic acid useful as 5HT receptor antagonists
US4713384A (en) * 1985-10-01 1987-12-15 Eli Lilly And Company Selective method for blocking 5HT2 receptors
US4734501A (en) * 1985-10-01 1988-03-29 Eli Lilly And Company N-alkylation of dihydrolysergic acid

Also Published As

Publication number Publication date
JPH02233680A (ja) 1990-09-17
US4914107A (en) 1990-04-03
ES2044422T3 (es) 1994-01-01
EP0379308A1 (de) 1990-07-25
DK0379308T3 (da) 1992-09-28
GR3005963T3 (de) 1993-06-07
CA2007472A1 (en) 1990-07-17
DE69000259D1 (de) 1992-09-24
ATE79539T1 (de) 1992-09-15
EP0379308B1 (de) 1992-08-19

Similar Documents

Publication Publication Date Title
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
SE8801813D0 (sv) Pharmaceutical composition
KR890701101A (ko) 제약학적 조성물
IT8621358A0 (it) Composizione farmaceutica adattivita' analgesica.
DE10199066I1 (de) Pharmazeutische Zusammensetzung
FI941245A (fi) Menetelmä 2'-deoksiguanosiinin asyylijohdannaisten valmistamiseksi
ES2067448T3 (es) Amidas de acidos piridina-2,4- y -2,5-dicarboxilicos, procedimiento para su preparacion, utilizacion de las mismas, asi como medicamentos a base de estos compuestos.
IT8620902A0 (it) Composizioni contenenti acido usnico o suoi derivati atte all'impiego nel trattamento della carie dentaria.
DK49488A (da) Anaestesi-praeparat
SE8404065D0 (sv) Novel biologically active compounds
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
IT1231509B (it) Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
SE8600658D0 (sv) Novel composition of matter
PT88682A (pt) A process for the preparation of pharmaceutical compositions containing a piperidinoalkanol-decongestant combination
DE69017969T2 (de) 2-Cyclohexylpropionsäure oder Derivate davon enthaltende Riechstoffzusammensetzung.
DE69000259D1 (de) Pharmazeutische zusammensetzung enthaltend 1-isopropyldihydrolysergsaeure.
ES2064652T3 (es) Derivados de naftaleno- y tetrahidronaftaleno-gem-difosfonato.
MX11584A (es) Composiciones farmaceuticas
ES2062214T3 (es) Derivados de aminooligohidroxi inhibidores de renina.
DK116687D0 (da) Farmaceutisk praeparat indeholdende aenovantroneae
ATE98478T1 (de) Calcitonin enthaltende pharmazeutische zusammensetzungen.
ATE78161T1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
IT9048526A0 (it) Composizione adesiva stabilizzante anidra per protesi dentarie.
NO910566L (no) Farmasoeytisk preparat.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee